1. Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?. (February 2022) Authors: Fanale, Daniele; Corsini, Lidia Rita; Scalia, Raimondo; Brando, Chiara; Cucinella, Alessandra; Madonia, Giorgio; Dimino, Alessandra; Filorizzo, Clarissa; Barraco, Nadia; Bono, Marco; Fiorino, Alessia; Magrin, Luigi; Sciacchitano, Roberta; Perez, Alessandro; Russo, Tancredi Didier Bazan; Pantuso, ... Journal: Critical reviews in oncology/hematology Issue: Volume 170(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and effectiveness of gemcitabine for the treatment of classic Kaposi's sarcoma without visceral involvement. (March 2022) Authors: Badalamenti, Giuseppe; Incorvaia, Lorena; Algeri, Laura; Bonasera, Annalisa; Dimino, Alessandra; Scalia, Raimondo; Cucinella, Alessandra; Madonia, Giorgio; Pomi, Federica Li; Galvano, Antonio; Gristina, Valerio; Toia, Francesca; Cordova, Adriana; Bazan, Viviana; Russo, Antonio Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗